These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8185386)

  • 1. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?
    Sessink PJ; Van de Kerkhof MC; Anzion RB; Noordhoek J; Bos RP
    Arch Environ Health; 1994; 49(3):165-9. PubMed ID: 8185386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures.
    Sessink PJ; Wittenhorst BC; Anzion RB; Bos RP
    Arch Environ Health; 1997; 52(3):240-4. PubMed ID: 9169636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study.
    Fransman W; Vermeulen R; Kromhout H
    Ann Occup Hyg; 2004 Apr; 48(3):237-44. PubMed ID: 15059800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals.
    Crul M; Hilhorst S; Breukels O; Bouman-d'Onofrio JRC; Stubbs P; van Rooij JG
    J Occup Environ Hyg; 2020; 17(7-8):343-352. PubMed ID: 32633703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of contamination with antineoplastic agents in a hospital pharmacy department.
    Sessink PJ; Anzion RB; Van den Broek PH; Bos RP
    Pharm Weekbl Sci; 1992 Feb; 14(1):16-22. PubMed ID: 1553250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.
    Fransman W; Vermeulen R; Kromhout H
    Int Arch Occup Environ Health; 2005 Jun; 78(5):403-12. PubMed ID: 15887018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)].
    Dolezalová L; Odráska P; Gorná L; Prudilová M; Vejpustková R; Bláha L
    Klin Onkol; 2009; 22(5):218-22. PubMed ID: 19886359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.
    Fransman W; Peelen S; Hilhorst S; Roeleveld N; Heederik D; Kromhout H
    Ann Occup Hyg; 2007 Apr; 51(3):231-9. PubMed ID: 17337460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
    Ensslin AS; Stoll Y; Pethran A; Pfaller A; Römmelt H; Fruhmann G
    Occup Environ Med; 1994 Apr; 51(4):229-33. PubMed ID: 8199663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
    Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
    Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents.
    Sessink PJ; Cerná M; Rössner P; Pastorková A; Bavarová H; Franková K; Anzion RB; Bos RP
    Mutat Res; 1994 Sep; 309(2):193-9. PubMed ID: 7520976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of hospital workers to airborne antineoplastic agents.
    deWerk Neal A; Wadden RA; Chiou WL
    Am J Hosp Pharm; 1983 Apr; 40(4):597-601. PubMed ID: 6846365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies.
    Ensslin AS; Huber R; Pethran A; Römmelt H; Schierl R; Kulka U; Fruhmann G
    Int Arch Occup Environ Health; 1997; 70(3):205-8. PubMed ID: 9298404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
    Wick C; Slawson MH; Jorgenson JA; Tyler LS
    Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.